Norges Bank’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
+89,820
| New | +$3.23M | ﹤0.01% | 1375 |
|
|
2025
Q1 | – | Sell |
-401,495
| Closed | -$12.1M | – | 1519 |
|
|
2024
Q4 | $12.1M | Buy |
+401,495
| New | +$12.1M | ﹤0.01% | 1322 |
|
|
2024
Q3 | – | Sell |
-597,300
| Closed | -$10.6M | – | 1588 |
|
|
2024
Q2 | $10.6M | Sell |
597,300
-114,390
| -16% | -$2.03M | ﹤0.01% | 1379 |
|
|
2024
Q1 | $10.8M | Sell |
711,690
-363,347
| -34% | -$5.53M | ﹤0.01% | 1425 |
|
|
2023
Q4 | $18.4M | Buy |
1,075,037
+152,925
| +17% | +$2.61M | ﹤0.01% | 1309 |
|
|
2023
Q3 | $7.71M | Hold |
922,112
| – | – | ﹤0.01% | 1564 |
|
|
2023
Q2 | $22.9M | Sell |
922,112
-21,057
| -2% | -$523K | ﹤0.01% | 1198 |
|
|
2023
Q1 | $14.2M | Sell |
943,169
-191,923
| -17% | -$2.89M | ﹤0.01% | 1431 |
|
|
2022
Q4 | $13.4M | Hold |
1,135,092
| – | – | ﹤0.01% | 1453 |
|
|
2022
Q3 | $6.72M | Buy |
1,135,092
+68,493
| +6% | +$405K | ﹤0.01% | 1667 |
|
|
2022
Q2 | $4.53M | Buy |
1,066,599
+51,177
| +5% | +$218K | ﹤0.01% | 1792 |
|
|
2022
Q1 | $9.66M | Sell |
1,015,422
-7,500
| -0.7% | -$71.3K | ﹤0.01% | 1715 |
|
|
2021
Q4 | $19.4M | Buy |
1,022,922
+198,098
| +24% | +$3.76M | ﹤0.01% | 1495 |
|
|
2021
Q3 | $27.5M | Sell |
824,824
-293,959
| -26% | -$9.78M | 0.01% | 1276 |
|
|
2021
Q2 | $43.4M | Buy |
1,118,783
+46,937
| +4% | +$1.82M | 0.01% | 1054 |
|
|
2021
Q1 | $51.7M | Sell |
1,071,846
-203,647
| -16% | -$9.82M | 0.01% | 949 |
|
|
2020
Q4 | $66.4M | Buy |
1,275,493
+15,083
| +1% | +$785K | 0.02% | 790 |
|
|
2020
Q3 | $33.7M | Buy |
1,260,410
+1,240,410
| +6,202% | +$33.2M | 0.01% | 1084 |
|
|
2020
Q2 | $390K | Buy |
+20,000
| New | +$390K | ﹤0.01% | 2058 |
|
|
2019
Q2 | – | Sell |
-100,000
| Closed | -$804K | – | 2129 |
|
|
2019
Q1 | $804K | Buy |
+100,000
| New | +$804K | ﹤0.01% | 2062 |
|